JP5932824B2 - グルカン - Google Patents

グルカン Download PDF

Info

Publication number
JP5932824B2
JP5932824B2 JP2013540441A JP2013540441A JP5932824B2 JP 5932824 B2 JP5932824 B2 JP 5932824B2 JP 2013540441 A JP2013540441 A JP 2013540441A JP 2013540441 A JP2013540441 A JP 2013540441A JP 5932824 B2 JP5932824 B2 JP 5932824B2
Authority
JP
Japan
Prior art keywords
glucan
gel
product
wound
ulcer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013540441A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014503621A5 (cg-RX-API-DMAC7.html
JP2014503621A (ja
Inventor
エングスタッド ロルフ
エングスタッド ロルフ
ネークランド トール
ネークランド トール
Original Assignee
ビオテック ファルマコン アルメン アクスイェ セルスカプ
ビオテック ファルマコン アルメン アクスイェ セルスカプ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ビオテック ファルマコン アルメン アクスイェ セルスカプ, ビオテック ファルマコン アルメン アクスイェ セルスカプ filed Critical ビオテック ファルマコン アルメン アクスイェ セルスカプ
Publication of JP2014503621A publication Critical patent/JP2014503621A/ja
Publication of JP2014503621A5 publication Critical patent/JP2014503621A5/ja
Application granted granted Critical
Publication of JP5932824B2 publication Critical patent/JP5932824B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2013540441A 2010-11-29 2011-11-29 グルカン Active JP5932824B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1020190.3 2010-11-29
GBGB1020190.3A GB201020190D0 (en) 2010-11-29 2010-11-29 Glucans
PCT/GB2011/052357 WO2012073018A1 (en) 2010-11-29 2011-11-29 Glucans

Publications (3)

Publication Number Publication Date
JP2014503621A JP2014503621A (ja) 2014-02-13
JP2014503621A5 JP2014503621A5 (cg-RX-API-DMAC7.html) 2014-09-04
JP5932824B2 true JP5932824B2 (ja) 2016-06-08

Family

ID=43500782

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013540441A Active JP5932824B2 (ja) 2010-11-29 2011-11-29 グルカン

Country Status (9)

Country Link
US (2) US9623043B2 (cg-RX-API-DMAC7.html)
EP (1) EP2646475B1 (cg-RX-API-DMAC7.html)
JP (1) JP5932824B2 (cg-RX-API-DMAC7.html)
KR (1) KR101874660B1 (cg-RX-API-DMAC7.html)
CN (1) CN103347900B (cg-RX-API-DMAC7.html)
CA (1) CA2818584C (cg-RX-API-DMAC7.html)
DK (1) DK2646475T3 (cg-RX-API-DMAC7.html)
GB (1) GB201020190D0 (cg-RX-API-DMAC7.html)
WO (1) WO2012073018A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT6145B (lt) 2014-04-14 2015-04-27 Uab "Biocentras" TERAPINĖ ß-GLIUKANŲ KOMPOZICIJA, MODULIUOJANTI ŽMOGAUS IMUNINĘ SISTEMĄ IR INICIJUOJANTI VĖŽINIŲ LĄSTELIŲ ARDYMĄ
CN108939130A (zh) * 2017-05-21 2018-12-07 衢州玛济克医疗科技有限公司 一种褥疮医用敷料及其生产方法
CN108904859A (zh) * 2018-07-23 2018-11-30 衢州玛济克医疗科技有限公司 一种痔疮医用敷料及其生产方法
CN108837175A (zh) * 2018-07-23 2018-11-20 衢州玛济克医疗科技有限公司 一种清创医用敷料及其生产方法
US12223039B2 (en) * 2019-08-29 2025-02-11 Flexxon Pte Ltd Methods and systems using an AI co-processor to detect anomalies caused by malware in storage devices
US11384160B1 (en) 2021-07-30 2022-07-12 Tissue repair ltd Method of making a beta glucan compound
US11572420B1 (en) 2021-07-30 2023-02-07 Tissue repair ltd Isolated biological polysaccharide compound, methods of use and methods of manufacture thereof
CN114014949B (zh) * 2021-11-15 2022-08-30 戚春建 一种水溶性酵母葡聚糖的制备方法
CN116139039B (zh) * 2023-02-07 2026-01-02 北京安德普泰医疗科技有限公司 一种含有乳酸低刺激性的组合物及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082936A (en) 1984-11-28 1992-01-21 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
EP0490995A1 (en) 1989-09-08 1992-06-24 Alpha Beta Technology Method for producing soluble glucans
US5158772A (en) * 1991-09-23 1992-10-27 Davis Walter B Unique bacterial polysaccharide polymer gel in cosmetics, pharmaceuticals and foods
NO300692B1 (no) 1994-04-29 1997-07-07 Biotec Mackzymal As Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
US5980918A (en) 1997-10-24 1999-11-09 Brennen Medical, Inc. β-D-glucan topical composition
AU3657100A (en) 1999-03-12 2000-10-04 Biotec Asa Use of water-soluble beta-(1,3) glucans as agents for producing therapeutic skintreatment agents
DE10022095B4 (de) 2000-05-08 2005-07-14 Südzucker AG Mannheim/Ochsenfurt Gel aus einem Poly-α-1,4-Glucan und Stärke
DE60135658D1 (de) * 2000-07-03 2008-10-16 Granate Seed Ltd In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung
CA2434938C (en) 2001-01-16 2012-02-28 Sloan-Kettering Institute For Cancer Research Compositions of glucan and a monoclonal antibody which exhibit an enhancement of the anti tumor activity of the antibody
GB0225502D0 (en) 2002-11-01 2002-12-11 Zoolife Internat Ltd Therapeutic and prophylactic preparations
WO2006123173A1 (en) 2005-05-19 2006-11-23 Kilda Biolink As Gelatin-containing topical composition
EP1957168A2 (en) 2005-11-30 2008-08-20 Ciba Holding Inc. Glucan compositions
CN101426510A (zh) * 2006-01-17 2009-05-06 斯隆-凯特林癌症研究院 增强治疗的酵母葡聚糖
US8323644B2 (en) * 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
WO2008102151A1 (en) 2007-02-21 2008-08-28 Biotec Pharmacon Asa Medical uses of glucans
CZ303471B6 (cs) 2007-10-03 2012-10-03 Contipro Biotech S.R.O. Prípravek pro hojení ran a prevenci adheze bandáže na ránu obsahující chitosan-glukan
CN101878033A (zh) * 2007-11-13 2010-11-03 生物科技医药公司 治疗或预防肠道炎症性疾病的方法
US20120288495A1 (en) * 2009-07-22 2012-11-15 Biothera, Inc. Therapeutic compositions and methods

Also Published As

Publication number Publication date
KR101874660B1 (ko) 2018-08-02
DK2646475T3 (en) 2017-02-27
CA2818584C (en) 2016-11-15
CN103347900A (zh) 2013-10-09
US20170056433A1 (en) 2017-03-02
WO2012073018A1 (en) 2012-06-07
US9623043B2 (en) 2017-04-18
US20130310338A1 (en) 2013-11-21
EP2646475A1 (en) 2013-10-09
CN103347900B (zh) 2016-06-01
GB201020190D0 (en) 2011-01-12
KR20130121137A (ko) 2013-11-05
JP2014503621A (ja) 2014-02-13
EP2646475B1 (en) 2017-01-25
US10646506B2 (en) 2020-05-12
CA2818584A1 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
JP6027013B2 (ja) グルカン組成物
US10646506B2 (en) Glucans
JP5932825B2 (ja) グルカンゲル
AU2013203451B8 (en) Glucan Gels
CN108042845A (zh) 一种白蛋白基水凝胶敷料及其制备方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140717

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140717

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150317

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150616

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150819

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20151020

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160210

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20160303

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160329

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160428

R150 Certificate of patent or registration of utility model

Ref document number: 5932824

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250